Review





Similar Products

86
3M Co aav1 aav2retro caggs egfp kobayashi lab n a chemicals
Aav1 Aav2retro Caggs Egfp Kobayashi Lab N A Chemicals, supplied by 3M Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 aav2retro caggs egfp kobayashi lab n a chemicals/product/3M Co
Average 86 stars, based on 1 article reviews
aav1 aav2retro caggs egfp kobayashi lab n a chemicals - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Charles River Laboratories aav1 gfp virus
Aav1 Gfp Virus, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 gfp virus/product/Charles River Laboratories
Average 86 stars, based on 1 article reviews
aav1 gfp virus - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

96
Addgene inc retrograde aav1 syn jgcamp8s wpre
Retrograde Aav1 Syn Jgcamp8s Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retrograde aav1 syn jgcamp8s wpre/product/Addgene inc
Average 96 stars, based on 1 article reviews
retrograde aav1 syn jgcamp8s wpre - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Addgene inc aav1
Aav1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1/product/Addgene inc
Average 96 stars, based on 1 article reviews
aav1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Vigene Biosciences aav1
Aav1, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1/product/Vigene Biosciences
Average 86 stars, based on 1 article reviews
aav1 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Vigene Biosciences aav1 icam2 shdpep1
Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
Aav1 Icam2 Shdpep1, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 icam2 shdpep1/product/Vigene Biosciences
Average 86 stars, based on 1 article reviews
aav1 icam2 shdpep1 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Vigene Biosciences aav1 scramble
Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
Aav1 Scramble, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 scramble/product/Vigene Biosciences
Average 86 stars, based on 1 article reviews
aav1 scramble - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

91
Addgene inc aav1 flexpkialpha ires nls mruby2
Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
Aav1 Flexpkialpha Ires Nls Mruby2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 flexpkialpha ires nls mruby2/product/Addgene inc
Average 91 stars, based on 1 article reviews
aav1 flexpkialpha ires nls mruby2 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

93
Addgene inc paav ef1a dio mscarlet aav1
Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
Paav Ef1a Dio Mscarlet Aav1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paav ef1a dio mscarlet aav1/product/Addgene inc
Average 93 stars, based on 1 article reviews
paav ef1a dio mscarlet aav1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

96
Addgene inc aav1 ef1a dio hchr2 h134r eyfp wpre hgh
Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
Aav1 Ef1a Dio Hchr2 H134r Eyfp Wpre Hgh, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav1 ef1a dio hchr2 h134r eyfp wpre hgh/product/Addgene inc
Average 96 stars, based on 1 article reviews
aav1 ef1a dio hchr2 h134r eyfp wpre hgh - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview of intravenous AAV1‐ICAM2‐shDpep1 injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.

Journal: MedComm

Article Title: Spatially Characterized Aortic Proteome Reveals Novel Regional Signatures and Glucocorticoid Receptor/Dipeptidase 1 Axis in Diabetic Vasculopathy

doi: 10.1002/mco2.70714

Figure Lengend Snippet: Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview of intravenous AAV1‐ICAM2‐shDpep1 injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.

Article Snippet: For AAV‐mediated Dpep1 knockdown in vivo, some db/m + and db/db mice were intravenously injected with AAV1‐scramble or AAV1‐ICAM2‐shDpep1 (2 × 10 11 vg per mouse), generated by Vigene Biosciences (Maryland, USA).

Techniques: Western Blot, Expressing, Ex Vivo, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Functional Assay, Injection, Isolation, Virus